Efficacy of TAP Block in Cesarean Section Patients

• Status: Completed
• Trial end date: 2013-12-01
• Target enrollment: 60
• Participant gender: Female

Summary

TAP Block done with 2 different concentrations of bupivacaine and placebo

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: New York Methodist Hospital
• Treatments: Bupivacaine

Criteria

Inclusion Criteria:

• Healthy pregnant women

Exclusion Criteria:

• Allergy to local anesthetics